Pharmaceuticals in Indonesia

Pharmaceuticals in Indonesia


  • Products Id :- OHMF4253
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceuticals in Indonesia

 

Summary

 

Pharmaceuticals in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

 

Synopsis

 

Essential resource for top-line data and analysis covering the Indonesia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

 

Key highlights

 

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Indonesian pharmaceuticals market had total revenues of USD 6.8bn in 2017, representing a compound annual growth rate (CAGR) of 8.4% between 2013 and 2017.

- The Indonesian pharmaceuticals market has experienced vast improvement following the introduction of its universal healthcare program Jaminan Kesehatan Nasional (JKN).

- Rising incomes and the development of a middle class has increased the number of people capable of accessing healthcare of a standard much closer to that in developed economies.

 

Scope

 

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Indonesia

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Indonesia

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia pharmaceuticals market with five year forecasts

 

Reasons to buy

 

- What was the size of the Indonesia pharmaceuticals market by value in 2017?

- What will be the size of the Indonesia pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Indonesia pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Indonesia's pharmaceuticals market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 18

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 23

PT Kalbe Farma Tbk 23

Novartis AG 27

Sanofi SA 30

Macroeconomic Indicators 33

Country data 33

Methodology 35

Industry associations 36

Related MarketLine research 36

Appendix 37

About MarketLine 37

List of Figures

Figure 1: Indonesia pharmaceuticals market value: USD billion, 2013-17

Figure 2: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Indonesia pharmaceuticals market share: % share, by value, 2017

Figure 4: Indonesia pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Indonesia, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2017

Figure 11: PT Kalbe Farma Tbk: revenues & profitability

Figure 12: PT Kalbe Farma Tbk: assets & liabilities

Figure 13: Novartis AG: revenues & profitability

Figure 14: Novartis AG: assets & liabilities

Figure 15: Sanofi SA: revenues & profitability

Figure 16: Sanofi SA: assets & liabilities

List of Tables

Table 1: Indonesia pharmaceuticals market value: USD billion, 2013-17

Table 2: Indonesia pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Indonesia pharmaceuticals market share: % share, by value, 2017

Table 4: Indonesia pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: PT Kalbe Farma Tbk: key facts

Table 6: PT Kalbe Farma Tbk: key financials (USD )

Table 7: PT Kalbe Farma Tbk: key financials (IDR)

Table 8: PT Kalbe Farma Tbk: key financial ratios

Table 9: Novartis AG: key facts

Table 10: Novartis AG: key financials (USD )

Table 11: Novartis AG: key financial ratios

Table 12: Sanofi SA: key facts

Table 13: Sanofi SA: key financials (USD )

Table 14: Sanofi SA: key financials (EUR)

Table 15: Sanofi SA: key financial ratios

Table 16: Indonesia size of population (million), 2013-17

Table 17: Indonesia gdp (constant 2005 prices, USD billion), 2013-17

Table 18: Indonesia gdp (current prices, USD billion), 2013-17

Table 19: Indonesia inflation, 2013-17

Table 20: Indonesia consumer price index (absolute), 2013-17

Table 21: Indonesia exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 25344
Site License
USD 700 INR 50687
Corporate User License
USD 1050 INR 76031

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com